Compare UNIT & BHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | UNIT | BHC |
|---|---|---|
| Founded | 2024 | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 2.3B |
| IPO Year | 2024 | 1996 |
| Metric | UNIT | BHC |
|---|---|---|
| Price | $4.08 | $8.39 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 8 | 7 |
| Target Price | ★ $8.81 | $8.40 |
| AVG Volume (30 Days) | ★ 5.4M | 3.8M |
| Earning Date | 11-09-2026 | 10-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 660.94 | 423.08 |
| EPS | N/A | ★ N/A |
| Revenue | $2,234,500,000.00 | ★ $8,724,000,000.00 |
| Revenue This Year | $64.73 | $7.43 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 91.49 | N/A |
| 52 Week Low | $3.91 | $4.33 |
| 52 Week High | $12.94 | $9.04 |
| Indicator | UNIT | BHC |
|---|---|---|
| Relative Strength Index (RSI) | 23.24 | 67.35 |
| Support Level | N/A | $5.48 |
| Resistance Level | $11.40 | N/A |
| Average True Range (ATR) | 0.42 | 0.44 |
| MACD | 0.04 | 0.08 |
| Stochastic Oscillator | 11.59 | 76.57 |
Uniti is the product of the August 2025 merger of the firm with Windstream, its former primary customer. The combined firm owns a 240,000 route-mile fiber network that serves enterprise and residential customers. Selling high-capacity fiber circuits to enterprises generates about 20% of consolidated revenue. Uniti's residential networks reach about 4.5 million households, mostly in less-populated markets in the Southeast, but only about 1.9 million of these locations have been upgraded with fiber. Legacy copper-cable networks serve the remainder. Residential services account for about a third of total revenue. Small business and wholesale services provided within this residential service territory account for about 20% of revenue.
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum of its revenue from the Bausch + Lomb segment.